UnitedHealth Group Incorporated (DE) ($UNH) Stock Forecast: Down 5.1% Today

What is UnitedHealth Group Incorporated (DE)?

A prominent healthcare company, UnitedHealth Group (UNH), offers a diverse array of health services with the healthcare sector receiving favorable market sentiment recently.

Why is UnitedHealth Group Incorporated (DE) going down?

UNH stock is down 5.1% on Oct 29, 2025 17:05

• UNH saw a decline in its stock despite announcing mixed Q3 results and revising its 2025 EPS forecast upwards. This decrease could be attributed to a significant drop in profits due to escalating medical expenses, causing unease among investors.
• The company's robust increase in commercial membership and strong performance by Optum Rx were eclipsed by a revenue shortfall and profit decrease, resulting in the downward trend in the market.
• Well-known hedge fund managers David Tepper and Michael Burry had anticipated a positive quarter from UNH following a notable slump in the previous year. The market's response to the results suggests that their anticipations may not have been wholly fulfilled.
• Even with UNH predicting a return to sustained growth and raising its 2025 guidance, the company's stock price fell, indicating that investors may have been expecting a more robust performance from UNH.

UNH Price Chart

UNH Technical Analysis

UNH News

Company News for Oct 29, 2025

Companies in The News Are: ...

https://www.zacks.com/stock/news/2780016/company-news-for-oct-29-2025

UnitedHealth Lifts EPS Outlook Despite Mixed Q3 Results: ETFs in Focus

UNH posts mixed Q3 results with a revenue miss but lifts its 2025 EPS outlook, boosting interest in healthcare ETFs like IHF and XLV.

https://www.zacks.com/stock/news/2779925/unitedhealth-lifts-eps-outlook-despite-mixed-q3-results-etfs-in-focus

UnitedHealth Q3 Earnings Beat on Rising Commercial Membership

UNH's Q3 earnings beat estimates on solid commercial membership gains and Optum Rx strength, though profits fall sharply on rising medical costs.

https://www.zacks.com/stock/news/2779400/unitedhealth-q3-earnings-beat-on-rising-commercial-membership

UnitedHealth Delivers The Quarter Tepper, Burry Have Been Waiting For - UnitedHealth Group ( NYSE:UNH )

It took a year of pain, but UnitedHealth Group Inc ( NYSE:UNH ) just gave hedge fund stars David Tepper and Michael Burry a clean bill of health. After a bruising 35% slide in the past 12 months, the insurance giant finally delivered a quarter that suggests the patient is stabilizing - and early ...

https://www.benzinga.com/trading-ideas/movers/25/10/48463071/unitedhealth-delivers-the-quarter-tepper-burry-have-been-waiting-for

Why Is UnitedHealth Stock Climbing Tuesday? - UnitedHealth Group ( NYSE:UNH )

UnitedHealth Group ( NYSE:UNH ) stock is trading higher after the insurance mammoth cited a return to sustained growth in its third-quarter 2025 earnings on Tuesday and raised its 2025 guidance. The company reported adjusted earnings of $2.92, down from $7.15 a year ago, beating the consensus ...

https://www.benzinga.com/markets/earnings/25/10/48459331/unitedhealth-lifts-outlook-as-ceo-promises-durable-growth-ahead

Trending Today

Hedera Hashgraph ($HBAR) Crypto Forecast: Up 5.0% Today

Soybeans ($SOY) Commodity Forecast: Down 0.4% Today

ZCash ($ZEC) Crypto Forecast: Up 11.6% Today

Duolingo Inc. ($DUOL) Stock Forecast: Down 6.9% Today

Centene Corporation ($CNC) Stock Forecast: Up 12.8% Today

American Electric Power Company Inc. ($AEP) Stock Forecast: Up 6.2% Today

DaVita Inc. ($DVA) Stock Forecast: Down 1.9% Today

Garmin Ltd. ($GRMN) Stock Forecast: Down 11.7% Today

Fiserv Inc. ($FI) Stock Forecast: Down 43.9% Today

PayPal Holdings Inc. ($PYPL) Stock Forecast: Down 5.3% Today

UnitedHealth Group Incorporated (DE) Price History

15.07.2025 - UNH Stock was up 10.9%

• UNH shares rose by 10.57% following Berkshire Hathaway's announcement of acquiring five million shares, showcasing strong confidence in the company.
• Investor Michael Burry's revelation of acquiring call contracts for 350,000 UNH shares also influenced the upward trajectory.
• Despite falling short of Q2 EPS projections, UNH saw a positive market response to the news of influential investors like Buffett and Burry increasing their stakes, hinting at a potential optimistic turnaround.
• The combined actions of Buffett and Burry likely reassured investors and generated a sense of positivity, leading to a substantial uptick in the stock price.

15.07.2025 - UNH Stock was up 11.0%

• Legendary investors Michael Burry and Warren Buffett disclosed significant positions in UNH, leading to a surge of 10.69% in after-hours trading.
• Michael Burry's purchase of call contracts against 350,000 shares of UNH and Warren Buffett's new stake in the company signaled a bold rebound bet, attracting investor interest.
• Despite the positive momentum, an investigation alert by Bragar Eagel & Squire, P.C. is urging long-term stockholders who suffered losses in UNH to discuss their options, adding a note of caution.
• Warren Buffett's Berkshire Hathaway revealed a new stake in UnitedHealth after secretly building the position for two quarters, showcasing confidence in the beleaguered insurer and contributing to the bullish market movement.

01.07.2025 - UNH Stock was down 5.2%

• Shares of UnitedHealth were downgraded by Baird and its price target was reduced, resulting in a more than 5% decline in stock value.
• The company is currently dealing with broader earnings and margin challenges across its business lines, with concerns raised about its 2026 outlook.
• Plans have been revealed by UnitedHealth Group to decrease its Medicare Advantage membership by 600,000 and undergo operational changes following unexpected medical costs amounting to $6.5 billion.
• The company's Q2 earnings have been impacted by rising medical costs, resulting in a 40% decrease in EPS despite revenue growth and the strong performance of Optum Rx.

29.09.2025 - UNH Stock was down 5.1%

• UNH saw a decline in its stock despite announcing mixed Q3 results and revising its 2025 EPS forecast upwards. This decrease could be attributed to a significant drop in profits due to escalating medical expenses, causing unease among investors.
• The company's robust increase in commercial membership and strong performance by Optum Rx were eclipsed by a revenue shortfall and profit decrease, resulting in the downward trend in the market.
• Well-known hedge fund managers David Tepper and Michael Burry had anticipated a positive quarter from UNH following a notable slump in the previous year. The market's response to the results suggests that their anticipations may not have been wholly fulfilled.
• Even with UNH predicting a return to sustained growth and raising its 2025 guidance, the company's stock price fell, indicating that investors may have been expecting a more robust performance from UNH.

28.09.2025 - UNH Stock was up 0.8%

• UNH stock saw a surge following the company's impressive earnings report for the third quarter of 2025. Adjusted earnings surpassed expectations, leading to a positive market response.
• The company's decision to raise its guidance for 2025 was well-received by investors, signaling a return to sustained growth and boosting confidence in the stock.
• Investor sentiment was further strengthened by reports of Warren Buffett taking a stake in UNH, contributing to the overall positive outlook for the company.
• The combination of strong earnings performance and optimistic future prospects were key drivers behind the notable uptick in UNH stock value.

15.07.2025 - UNH Stock was up 13.6%

• UNH stock saw a significant surge of 10.57% following noteworthy disclosures by renowned investors Warren Buffett and Michael Burry, indicating a strong show of faith in the company's potential.
• Investors responded positively to the news, interpreting the investments made by Buffett's Berkshire Hathaway and Burry as a confident move towards a robust recovery for UNH.
• Despite falling short of Q2 EPS expectations, UNH's revenue of $111.62 billion and the endorsement from influential investors contributed to the stock's remarkable upward momentum.
• Market sentiment suggests that UNH may have reached a turning point, with the latest developments sparking optimism and driving the stock price upwards.

29.06.2025 - UNH Stock was down 5.3%

• Q2 earnings for UNH fell below estimates, with EPS at $4.08 not meeting expectations.
• The company made a substantial downward revision to its full-year 2025 EPS guidance, sparking investor worries.
• Rising medical costs are affecting insurers like UnitedHealth, leading to a dim outlook on 2025 earnings.
• The initiation of a class action lawsuit against UnitedHealth contributed to the pessimistic atmosphere surrounding the stock.

29.06.2025 - UNH Stock was down 6.3%

• UnitedHealth (UNH) saw a decline in its stock today as it missed Q2 earnings expectations. This was primarily due to higher medical costs, resulting in a 40% drop in EPS.
• In Q2, UnitedHealth reported an EPS of $4.08, falling short of the predicted $4.95. Revenue increased by 13% to $111.62 billion, slightly below the expected amount.
• The company lowered its full-year 2025 EPS guidance to at least $16, down significantly from the previous forecast of $26-$26.50. Revenue projections were also decreased.
• Additionally, the company faced the challenge of a class-action lawsuit, which may have heightened uncertainties among investors and added to the negative outlook.

05.07.2025 - UNH Stock was up 5.1%

• UNH had a strong bullish movement today despite challenges in its business operations.
• The stock initially decreased by over 5% following a downgrade and price target cut, but later recovered and surged upwards.
• UNH's strategic decision to implement an AI-led overhaul and reduce its membership numbers to recover margins seems to have contributed to the stock's positive movement.
• The market is responding positively to UnitedHealth's measures to address financial challenges and enhance operational efficiency.

03.09.2025 - UNH Stock was up 5.0%

• Positive market sentiment and investor confidence in the healthcare sector likely drove UNH's bullish movement.
• Potential changes in drug pricing dynamics resulting from Pfizer's deal with Washington could have indirectly benefited UNH.
• Despite some identified bearish options trading, overall market sentiment and analyst recommendations support UNH as an appealing investment, heightening investor interest.
• Cleerly's AI cardiovascular imaging solutions, supported by Cigna, showcase ongoing innovation in the healthcare industry, which could positively impact companies like UnitedHealth Group.

31.06.2025 - UNH Stock was down 5.2%

• UNH recently faced a bearish movement attributed to a $6.5 billion medical cost blowout, resulting in the loss of 600,000 Medicare Advantage members and the initiation of an operational overhaul.
• Despite revenue growth and a strong performance in Optum Rx, UNH's Q2 earnings fell short of estimates due to rising medical costs, significantly impacting EPS.
• Although the company has expressed optimism for a better 2026, it has revised its full-year 2025 EPS guidance downward, leading to investor worries regarding future profitability.
• The general market sentiment towards health insurers is currently pessimistic, as the industry grapples with escalating costs and operational hurdles.

29.06.2025 - UNH Stock was down 6.1%

• Q2 earnings for UNH missed estimates by 15.70% and revenue slightly exceeded expectations.
• The company's 2025 earnings guidance was lower than anticipated, mainly due to high medical costs impacting insurers.
• A class action lawsuit has been filed against UNH, potentially increasing legal pressure and uncertainty for investors.
• Despite leveraging on Optum's diversified growth and value-based care to combat industry challenges, concerns over long-term performance and missed earnings have influenced UNH's stock price negatively.